166 related articles for article (PubMed ID: 30539763)
1. Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding EJ; Advani R; Rosenberg SA; Hoppe RT
Radiother Oncol; 2018 Dec; 129(3):507-512. PubMed ID: 30539763
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).
Wirth A; Prince HM; Roos D; Gibson J; O'Brien P; Zannino D; Khodr B; Stone JM; Davis S; Hertzberg M
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1158-1166. PubMed ID: 30553941
[TBL] [Abstract][Full Text] [Related]
3. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
[TBL] [Abstract][Full Text] [Related]
4. The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant.
Furlan C; Matrone F; Rupolo M; Ciancia R; Zanet E; Montante B; Palazzari E; Navarria F; Trovo M; Bulian P; Spina M; Coassin E; Mascarin M; De Paoli A; Franchin G; Michieli M
Cancer Radiother; 2019 Sep; 23(5):378-384. PubMed ID: 31178272
[TBL] [Abstract][Full Text] [Related]
5. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
6. Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Edwards-Bennett SM; Jacks LM; Moskowitz CH; Wu EJ; Zhang Z; Noy A; Portlock CS; Straus DJ; Zelenetz AD; Yahalom J
Ann Oncol; 2010 Mar; 21(3):574-581. PubMed ID: 19759185
[TBL] [Abstract][Full Text] [Related]
7. Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?
Kahn S; Flowers C; Xu Z; Esiashvili N
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):175-80. PubMed ID: 20732769
[TBL] [Abstract][Full Text] [Related]
8. Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
Advani RH; Hoppe RT; Maeda LS; Baer DM; Mason J; Rosenberg SA; Horning SJ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1374-9. PubMed ID: 20934280
[TBL] [Abstract][Full Text] [Related]
9. Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.
Kumar A; Burger IA; Zhang Z; Drill EN; Migliacci JC; Ng A; LaCasce A; Wall D; Witzig TE; Ristow K; Yahalom J; Moskowitz CH; Zelenetz AD
Haematologica; 2016 Oct; 101(10):1237-1243. PubMed ID: 27390360
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492.
Horning SJ; Williams J; Bartlett NL; Bennett JM; Hoppe RT; Neuberg D; Cassileth P
J Clin Oncol; 2000 Mar; 18(5):972-80. PubMed ID: 10694546
[TBL] [Abstract][Full Text] [Related]
11. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
[TBL] [Abstract][Full Text] [Related]
12. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
13. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
[TBL] [Abstract][Full Text] [Related]
14. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.
Horning SJ; Hoppe RT; Breslin S; Bartlett NL; Brown BW; Rosenberg SA
J Clin Oncol; 2002 Feb; 20(3):630-7. PubMed ID: 11821442
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
16. Is combined modality therapy necessary for advanced Hodgkin's disease?
Mendenhall NP; Bennett CJ; Lynch JW
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):583-92. PubMed ID: 9231683
[TBL] [Abstract][Full Text] [Related]
17. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
18. Stage III follicular lymphoma: long-term follow-up and patterns of failure.
Ha CS; Kong JS; McLaughlin P; Tucker SL; Fayad LE; Hess MA; Wilder RB; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):748-54. PubMed ID: 14529780
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
